“You're, hopefully, knock on wood, should be launching a drug, pretty soon over literally the next two months, two and a half months or so”
→ Read the source episode
Brepacitinib receives FDA approval and is launched commercially
John predicts Coursera will run two studies (biomarker and outcomes-based) for their PCSK9/angiotensinogen siRNA program
Greg Savonovich predicts the biotech sector will continue to rally through the rest of 2026
John predicts France will win the third-place match and Argentina will beat France 3-2 in the World Cup final on Sunday
Yaron Werber predicts Gilead's Anido Cell (anti-BCMA CAR-T) will receive FDA approval in December 2026
Yaron Werber predicts Forte's phase 2b celiac disease study will be positive
Yaron Werber expects Forte will report phase 2b celiac and phase 1b alopecia areata data by end of 2026
Summaries are ours; the quote is a verbatim transcript excerpt. Our resolution criteria are editorial and disputable. How this works.